Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value
$640.61M
Total Bought
$232.94M
Total Sold
$149.90M
Net Transaction
+$83.04M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX SA(ABVX)1,267,0001,325,000+58,0009,693112,49317.56%+102,800
DIANTHUS THERAPEUTICS INC(DNTH)2,341,6672,416,667+75,00043,62595,09614.84%+51,471
GOSSAMER BIO INC(GOSS)18,350,00017,050,000-1,300,00022,57144,8427.00%+22,271
COGENT BIOSCIENCES INC(COGT)2,763,0002,874,111+111,11119,83841,2726.44%+21,434
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)01,043,110+1,043,110012,0791.89%+12,079
MIND MEDICINE MINDMED INC2,130,0002,130,000013,82425,1133.92%+11,289
CIDARA THERAPEUTICS INC0100,000+100,00009,5761.49%+9,576
KYMERA THERAPEUTICS INC(KYMR)266,000360,000+94,00011,60820,3763.18%+8,768
MERUS N V389,000308,000-81,00020,46128,9984.53%+8,537
OCULAR THERAPEUTIX INC(OCUL)2,425,0002,624,000+199,00022,50430,6754.79%+8,171
CENTESSA PHARMACEUTICALS PLC1,030,000830,000-200,00013,53420,1283.14%+6,593
CORBUS PHARMACEUTICALS HLDGS(CRBP)1,115,0001,115,00007,69414,1052.20%+6,411
PHARVARIS N V
COM
672,595722,595+50,00011,83818,0292.81%+6,191
TREVI THERAPEUTICS INC(TRVI)3,672,0002,815,000-857,00020,08625,7574.02%+5,671
APELLIS PHARMACEUTICALS INC
COM
903,500903,500015,64020,4463.19%+4,807
PEPGEN INC(PEPG)0700,000+700,00003,2340.50%+3,234
STRUCTURE THERAPEUTICS INC0115,000+115,00003,2200.50%+3,220
MAZE THERAPEUTICS INC(MAZE)177,667177,66702,1804,6070.72%+2,427
KALVISTA PHARMACEUTICALS INC1,273,3331,273,333014,39515,5092.42%+1,114
DBV TECHNOLOGIES S A(DBVT)1,018,0211,018,02109,31510,1801.59%+865
TAYSHA GENE THERAPIES INC(TSHA)12,592,5009,067,500-3,525,00029,08929,6514.63%+562
NUVATION BIO INC(NUVB)154,112104,112-50,0003013850.06%+85
NEUROGENE INC(NGNE)303,000252,000-51,0004,5304,3670.68%-163
UNICYCIVE THERAPEUTICS INC(UNCY)1,000,0001,000,00004,7704,3600.68%-410
ERASCA INC(ERAS)700,0000-700,0008890—-889
KALARIS THERAPEUTICS INC(KLRS)360,0000-360,0009610—-961
HELIX ACQUISITION CORP II250,0000-250,0002,6630—-2,662
NUVATION BIO INC(NUVB)7,691,3342,633,334-5,058,00014,9989,7431.52%-5,255
ARRIVENT BIOPHARMA INC(AVBP)1,946,0541,971,054+25,00042,36636,3665.68%-6,000
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)148,0000-148,0006,9860—-6,986
TOURMALINE BIO INC905,0000-905,00014,4710—-14,471
ATYR PHARMA INC3,820,0000-3,820,00019,3670—-19,367
ARS PHARMACEUTICALS INC(SPRY)1,350,0000-1,350,00023,5580—-23,557
VERONA PHARMA PLC337,0000-337,00031,8730—-31,873
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q3 2025 | TickerTrail